When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Vaccinex (NASDAQ:VCNX)jumps 11% premarket on heels of a clinical collaboration agreement with Merck (NYSE:MRK) to evaluate the combination of company's investigational SEMA4D inhibitor, pepinemab, and Merck’s anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in the treatment of patients with advanced, recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
More news on: Vaccinex, Inc., Merck & Co., Inc., Healthcare stocks news, Stocks on the move,